Intravenous - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4333241
  • Report
  • Region: Global
  • 175 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Angiodynamics, Inc.
  • B. Braun Melsungen Ag
  • Fresenius Se & Co. Kgaa
  • Insulet Corporation
  • Medtronic Inc.
  • Pfizer Inc.
  • MORE
Intravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy is the fastest way of delivering the fluids to different parts of the body. In cases, wherein the patient requires rapid medication, such as heart attack, stroke, and poisoning, IV medication is preferred. Some of the drugs administered intravenously are chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, drugs for low blood pressure, and others. IV therapy operates with a rapid speed, ease to monitor, and avoids side effects on gastrointestinal systems.

Increase in prevalence of diseases, such as cardiac disorders, blood pressure, cancer; and increase in road accidents drive the market growth. In addition, growth in surgical procedures, rise in trauma cases, rapid technological advancements, increase in awareness among the population, and surge in geriatric population fuel the market further. However, high risk of allergic reaction is expected to restrain the growth of the market during the forecast period. The global intravenous therapy and vein access market has accounted for $18,000 million in 2016, and is estimated to reach $27,971 million by 2023, growing at a CAGR of 6.4% during the forecast period.

The market is segmented on the basis of product type, medical application, end user, and geography. By product type, it is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. Medical applications covered in the study include volume expanders, medication administration, blood-based products, and nutrition & buffer solution. Based on end user, it is classified into hospitals, ambulatory surgical centers, and clinics. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STKEHOLDERS

The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

Implantable Ports
Single Lumen Implantable Port
Double Lumen Implantable Port
Intravenous Catheters
Peripheral Intravenous Catheter
Central Intravenous Catheter
Peripherally Inserted Central Catheter
Hypodermic Needles
Infusion Pumps
Other Products
By Medical Application

Volume Expanders
Medication Administration
Blood-based Products
Nutrition & Buffer Solution
By End User

Hospitals
Ambulatory Surgical Centers
Clinics
By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
List of players profiled in the report

Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Medical Corporation
Teleflex Medical Inc.
Medtronic Inc.
Smith & Nephew plc.
AngioDynamics, Inc.
Pfizer Inc.
Insulet Corporation
Fresenius SE & Co. KGaA
List of other players (These companies are not profiled in the report and same can be done on demand)

iRadimed Corporation
Baxter International Inc.
BioScrip, Inc.
Grifols, S.A.
JW Life Science Co. Ltd.
BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
CVS Health Corporation
Vifor Pharma Group
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Angiodynamics, Inc.
  • B. Braun Melsungen Ag
  • Fresenius Se & Co. Kgaa
  • Insulet Corporation
  • Medtronic Inc.
  • Pfizer Inc.
  • MORE
CHAPTER 1 INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENT
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1.KEY FINDINGS OF THE STUDY
2.2.CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTERS FIVE FORCES ANALYSIS

3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of substitutes
3.3.4.Threat of new entrants
3.3.5.Competitive rivalry

3.4.TOP PLAYERS POSITIONING, 2016
3.5.MARKET DYNAMICS

3.5.1.Drivers

3.5.1.1.Increase in geriatric population
3.5.1.2.Increase in prevalence of chronic diseases
3.5.1.3.Increase in trauma cases and traffic accidents
3.5.1.4.Wide advantages of IV therapy and vein access devices

3.5.2.Restraint

3.5.2.1.Risk of allergic reaction and requirement of skilled professionals
3.5.2.2.Stringent government regulations

3.5.3.Opportunity

3.5.3.1.Lucrative opportunities from emerging economies

CHAPTER 4 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.IMPLANTABLE PORT

4.2.1.Key market trends
4.2.2.Key growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Single Lumen Implantable Port

4.2.4.1.Market size and forecast

4.2.5.Double Lumen Implantable Port

4.2.5.1.Market size and forecast

4.3.INTRAVENOUS CATHETER

4.3.1.Key market trends
4.3.2.Key growth factors and opportunities
4.3.3.Market size and forecast
4.3.4.Peripheral Intravenous Catheter

4.3.4.1.Market size and forecast

4.3.5.Central Intravenous Catheter

4.3.5.1.Market size and forecast

4.3.6.Peripherally Inserted Central Catheter

4.3.6.1.Market size and forecast

4.4.HYPODERMIC NEEDLES

4.4.1.Key market trends
4.4.2.Key growth factors and opportunities
4.4.3.Market size and forecast

4.5.INFUSION PUMPS

4.5.1.Key market trends
4.5.2.Key growth factors and opportunities
4.5.3.Market size and forecast

4.6.OTHER PRODUCTS

4.6.1.Key market trends
4.6.2.Key growth factors and opportunities
4.6.3.Market size and forecast

CHAPTER 5 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY MEDICAL APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.VOLUME EXPANDERS

5.2.1.Market size and forecast

5.3.MEDICATION ADMINISTRATION

5.3.1.Market size and forecast

5.4.BLOOD BASED PRODUCTS

5.4.1.Market size and forecast

5.5.NUTRITION AND BUFFER SOLUTION

5.5.1.Market size and forecast

CHAPTER 6 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER

6.1.OVERVIEW

6.1.1.Market size and forecast

6.2.HOSPITALS

6.2.1.Market size and forecast

6.3.AMBULATORY SURGICAL CENTERS

6.3.1.Market size and forecast

6.4.CLINICS

6.4.1.Market size and forecast

CHAPTER 7 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY

7.1.OVERVIEW

7.1.1.Market size and forecast

7.2.NORTH AMERICA

7.2.1.Key market trends
7.2.2.Key growth factors and opportunities
7.2.3.Market size and forecast
7.2.4.U.S. market size and forecast
7.2.5.Canada market size and forecast
7.2.6.Mexico market size and forecast

7.3.EUROPE

7.3.1.Key market trends
7.3.2.Key growth factors and opportunities
7.3.3.Market size and forecast
7.3.4.Germany market size and forecast
7.3.5.France market size and forecast
7.3.6.UK market size and forecast
7.3.7.Italy market size and forecast
7.3.8.Spain market size and forecast
7.3.9.Rest of Europe market size and forecast

7.4.ASIA-PACIFIC

7.4.1.Key market trends
7.4.2.Key growth factors and opportunities
7.4.3.Market size and forecast
7.4.4.Japan market size and forecast
7.4.5.China market size and forecast
7.4.6.India market size and forecast
7.4.7.Rest of Asia-Pacific market size and forecast

7.5.LAMEA

7.5.1.Key market trends
7.5.2.Key growth factors and opportunities
7.5.3.Market size and forecast
7.5.4.Latin America market size and forecast
7.5.5.Middle East market size and forecast
7.5.6.Africa market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1.BECTON, DICKINSON AND COMPANY

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4. Key Strategic Moves & Developments

8.2. B.BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4.Key Strategic Moves & Developments

8.3.TERUMO MEDICAL CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4.Key Strategic Moves & Developments

8.4.TELEFLEX MEDICAL INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4.Key Strategic Moves & Developments

8.5.MEDTRONIC INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4. Key Strategic Moves & Developments

8.6.SMITH & NEPHEW PLC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4.Key Strategic Moves & Developments

8.7.ANGIODYNAMICS, INC.

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4.Key Strategic Moves & Developments

8.8.PFIZER INC.

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4. Key Strategic Moves & Developments

8.9.INSULET CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4. Key Strategic Moves & Developments

8.10.FRESENIUS SE & CO. KGAA

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4. Key Strategic Moves & Developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Angiodynamics, Inc.
  • B. Braun Melsungen Ag
  • Fresenius Se & Co. Kgaa
  • Insulet Corporation
  • Medtronic Inc.
  • Pfizer Inc.
  • MORE
According to a new report titled, Intravenous Therapy and Vein Access Devices Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global intravenous therapy and vein access devices market was valued at $18,000 million in 2016, and is projected to reach $27,971 million by 2023, growing at a CAGR of 6.4% from 2017 to 2023. The intravenous catheter segment accounted for one-third share of the total market in 2016.

Intravenous therapy is used to administer medicine, nutrients, blood, and buffer solution directly into the vein. IV therapy works faster for the quick immune system response and relief from chronic diseases as compared to oral mode of medication. IV therapy can be easily monitored and has infusion pump that controls the volume of the substance to be administered in the body. Increase in incidence of chronic disorders, surge in trauma cases, rise in geriatric population, and growth in road accidents are expected to boost the market growth during the analysis period. However, lack of skilled professionals is projected to restrain the market growth during the forecast period.
The intravenous catheter market segment held the highest share in 2016, owing to increase in healthcare expenditure and continuous advancement in intravenous catheter technology, which are expected to support the growth of this market during the forecast period.
Medical administration held the highest market share in 2016, owing to wide use of IV therapy for medication administration as it is most effective, fast acting, and suitable for unconscious and emergency patients. The hospitals segment gained the highest market share in 2016, owing to highest number of surgical procedures in hospitals resulting in usage of IV therapy.
North America accounted for two-fifths share in 2016, and is expected to dominate the market throughout the forecast period. This is attributed to increase in incidence of chronic diseases due to rise in geriatric population, well-established healthcare systems, and increase in awareness among the population toward timely diagnosis and treatment of diseases. In addition, higher adoption rate for technologically advanced devices is anticipated to provide new growth opportunities for the key players in the market. However, Asia-Pacific is projected to grow at the highest growth rate during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, growth in demand for healthcare services from large pool of patient population, and improvement in healthcare infrastructure.

Key Findings of the Intravenous Therapy and Vein Access Devices Market:
By product, the intravenous catheter segment dominated the market in 2016, and is projected to grow at the highest CAGR during the analysis period 2017-2023.
By application, the medication administration segment accounted for the highest share in 2016.
U.S. was the major shareholder in the North America IV therapy and vein access devices market in 2016.
Asia-Pacific is expected to witness the highest growth rate.
China is expected to grow at the highest CAGR in the Asia-Pacific IV therapy and vein access devices market in 2016.
The major players profiled in the global IV therapy and vein access devices market are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Medical Corporation, Teleflex Medical Inc., Medtronic Inc., Smith & Nephew plc., AngioDynamics, Inc., Pfizer Inc., Insulet Corporation, and Fresenius SE & Co. KGaA.
Note: Product cover images may vary from those shown
5 of 5
  • Becton, Dickinson And Company
  • B. Braun Melsungen Ag
  • Terumo Medical Corporation
  • Teleflex Medical Inc.
  • Medtronic Inc.
  • Smith & Nephew Plc.
  • Angiodynamics, Inc.
  • Pfizer Inc.
  • Insulet Corporation
  • Fresenius Se & Co. Kgaa
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll